153 related articles for article (PubMed ID: 25773176)
1. Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin.
Nishie W; Natsuga K; Iwata H; Izumi K; Ujiie H; Toyonaga E; Hata H; Nakamura H; Shimizu H
Am J Pathol; 2015 May; 185(5):1361-71. PubMed ID: 25773176
[TBL] [Abstract][Full Text] [Related]
2. Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid.
Nishie W; Lamer S; Schlosser A; Licarete E; Franzke CW; Hofmann SC; Jackow J; Sitaru C; Bruckner-Tuderman L
J Immunol; 2010 Oct; 185(8):4938-47. PubMed ID: 20861347
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.
Natsuga K; Nishie W; Shinkuma S; Ujiie H; Nishimura M; Sawamura D; Shimizu H
J Immunol; 2012 Jun; 188(11):5792-9. PubMed ID: 22523387
[TBL] [Abstract][Full Text] [Related]
4. C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies.
Toyonaga E; Nishie W; Izumi K; Natsuga K; Ujiie H; Iwata H; Yamagami J; Hirako Y; Sawamura D; Fujimoto W; Shimizu H
J Invest Dermatol; 2017 Dec; 137(12):2552-2559. PubMed ID: 28842325
[TBL] [Abstract][Full Text] [Related]
5. High Expression of Collagen XVII Compensates for its Depletion Induced by Pemphigoid IgG in the Oral Mucosa.
Kamaguchi M; Iwata H; Ujiie H; Natsuga K; Nishie W; Kitagawa Y; Shimizu H
J Invest Dermatol; 2018 Aug; 138(8):1707-1715. PubMed ID: 29530535
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies.
Nishie W
Methods Mol Biol; 2013; 961():363-9. PubMed ID: 23325657
[TBL] [Abstract][Full Text] [Related]
8. Epitope-Dependent Pathogenicity of Antibodies Targeting a Major Bullous Pemphigoid Autoantigen Collagen XVII/BP180.
Wada M; Nishie W; Ujiie H; Izumi K; Iwata H; Natsuga K; Nakamura H; Kitagawa Y; Shimizu H
J Invest Dermatol; 2016 May; 136(5):938-946. PubMed ID: 26827765
[TBL] [Abstract][Full Text] [Related]
9. Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models.
Ujiie H; Yoshimoto N; Natsuga K; Muramatsu K; Iwata H; Nishie W; Shimizu H
Front Immunol; 2019; 10():1410. PubMed ID: 31275329
[TBL] [Abstract][Full Text] [Related]
10. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.
Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H
Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750
[TBL] [Abstract][Full Text] [Related]
11. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.
Nishie W
J Dermatol Sci; 2014 Mar; 73(3):179-86. PubMed ID: 24434029
[TBL] [Abstract][Full Text] [Related]
12. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
[TBL] [Abstract][Full Text] [Related]
13. What's new in bullous pemphigoid.
Ujiie H; Shibaki A; Nishie W; Shimizu H
J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
[TBL] [Abstract][Full Text] [Related]
14. Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.
Pigors M; Patzelt S; Reichhelm N; Dworschak J; Khil'chenko S; Emtenani S; Bieber K; Hofrichter M; Kamaguchi M; Goletz S; Köhl G; Köhl J; Komorowski L; Probst C; Vanderheyden K; Balbino B; Ludwig RJ; Verheesen P; Schmidt E
J Pathol; 2024 Feb; 262(2):161-174. PubMed ID: 37929639
[TBL] [Abstract][Full Text] [Related]
15. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.
Ujiie H; Shibaki A; Nishie W; Sawamura D; Wang G; Tateishi Y; Li Q; Moriuchi R; Qiao H; Nakamura H; Akiyama M; Shimizu H
J Immunol; 2010 Feb; 184(4):2166-74. PubMed ID: 20089696
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of bullous pemphigoid.
Ujiie H; Nishie W; Shimizu H
Dermatol Clin; 2011 Jul; 29(3):439-46, ix. PubMed ID: 21605809
[TBL] [Abstract][Full Text] [Related]
17. Life before and beyond blistering: The role of collagen XVII in epidermal physiology.
Natsuga K; Watanabe M; Nishie W; Shimizu H
Exp Dermatol; 2019 Oct; 28(10):1135-1141. PubMed ID: 29604146
[TBL] [Abstract][Full Text] [Related]
18. Collagen XVII Processing and Blistering Skin Diseases.
Nishie W
Acta Derm Venereol; 2020 Feb; 100(5):adv00054. PubMed ID: 32039455
[TBL] [Abstract][Full Text] [Related]
19. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of bullous pemphigoid.
Ujiie H; Nishie W; Shimizu H
Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
